news
An AI tool has identified adalimumab, a drug used for…
13 February 2025 | By Drug Target Review
An AI tool has identified adalimumab, a drug used for arthritis and Crohn’s disease, as a life-saving treatment for rare Castleman’s disease (iMCD). This finding offers hope for patients with the condition.